TSX-V:KDA • CA48669F1071
The current stock price of KDA.CA is 0.21 CAD. In the past month the price increased by 16.67%. In the past year, price decreased by -19.23%.
ChartMill assigns a technical rating of 1 / 10 to KDA.CA. When comparing the yearly performance of all stocks, KDA.CA is a bad performer in the overall market: 90.51% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to KDA.CA. KDA.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months KDA.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 20.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -73.21% | ||
| ROE | -73.63% | ||
| Debt/Equity | 0.04 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VHI | VITALHUB CORP | 32.96 | 505.208M | ||
| NURS | HYDREIGHT TECHNOLOGIES INC | 12.92 | 195.067M | ||
| ADK | DIAGNOS INC | N/A | 36.123M | ||
| AVCR | AVRICORE HEALTH INC | N/A | 7.597M | ||
| KOVO | KOVO+ HOLDINGS INC | N/A | 4.422M | ||
| EKG | CARDIOCOMM SOLUTIONS INC | N/A | 1.976M |
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
KDA Group, Inc. engages in the provision of solutions and services to the pharmaceutical market. The company is headquartered in Thetford Mines, Quebec. The company went IPO on 2009-09-09. The firm operates through Pharmaceutical Technology segment. The company is focused on developing technological products across four different platforms: KRx, Medherize, CareMedic and Adherize+. The KRx is an advanced electronic prescription platform that simplifies and secures the prescribing process for medical clinics. Medherize is a specialized module of Adherize+, which focuses on patients undergoing complex therapies, such as oral oncology treatments. CareMedic is its integrated digital health record and care coordination platform. The company centralizes patient information, including medical history, lab results, allergies, and medication schedules and enables secure communication among providers and with patients. Adherize+ is an intelligent patient engagement platform designed to monitor treatment adherence and provide tailored interventions.
KDA GROUP INC
Bureau 300, 1351, rue Notre-Dame Est
Thetford Mines QUEBEC G6G 0G5 CA
CEO: Sylvain Duvernay
Employees: 4
Phone: 15147150376
KDA Group, Inc. engages in the provision of solutions and services to the pharmaceutical market. The company is headquartered in Thetford Mines, Quebec. The company went IPO on 2009-09-09. The firm operates through Pharmaceutical Technology segment. The company is focused on developing technological products across four different platforms: KRx, Medherize, CareMedic and Adherize+. The KRx is an advanced electronic prescription platform that simplifies and secures the prescribing process for medical clinics. Medherize is a specialized module of Adherize+, which focuses on patients undergoing complex therapies, such as oral oncology treatments. CareMedic is its integrated digital health record and care coordination platform. The company centralizes patient information, including medical history, lab results, allergies, and medication schedules and enables secure communication among providers and with patients. Adherize+ is an intelligent patient engagement platform designed to monitor treatment adherence and provide tailored interventions.
The current stock price of KDA.CA is 0.21 CAD.
KDA.CA does not pay a dividend.
KDA.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
KDA GROUP INC (KDA.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).
KDA GROUP INC (KDA.CA) will report earnings on 2026-03-13.